Depletion of cytochrome P-450 and alterations in activities of drug metabolizing enzymes by S-(1,2-dichlorovinyl)-L-cysteine in mouse kidney cortex.
Hoechst AG, Frankfurt/Main, FRG.
C
C
Cojocel
D
D
Mayer
D000818:Animals; D003545:Cysteine / Q000031:analogs & derivatives* / Q000494:pharmacology; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003573:Cytochrome b Group / Q000378:metabolism; D015786:Cytochromes b5; D007672:Kidney Cortex / Q000187:drug effects / Q000201:enzymology*; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D051379:Mice; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D006899:Mixed Function Oxygenases / Q000378:metabolism*
D065607:Cytochrome P-450 Enzyme Inhibitors; D003573:Cytochrome b Group; C039961:S-(1,2-dichlorovinyl)cysteine; D015786:Cytochromes b5; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D003545:Cysteine